Defining the South African Acute Respiratory Infectious Disease Season.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
07 01 2023
Historique:
received: 08 12 2022
revised: 04 01 2023
accepted: 05 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

The acute respiratory infectious disease season, or colloquially the "flu season", is defined as the annually recurring period characterized by the prevalence of an outbreak of acute respiratory infectious diseases. It has been widely agreed that this season spans the winter period globally, but the precise timing or intensity of the season onset in South Africa is not well defined. This limits the efficacy of the public health sector to vaccinate for influenza timeously and for health facilities to synchronize efficiently for an increase in cases. This study explores the statistical intensity thresholds in defining this season to determine the start and finish date of the acute respiratory infectious disease season in South Africa. Two sets of data were utilized: public-sector hospitalization data that included laboratory-tested RSV and influenza cases and private-sector medical insurance claims under ICD 10 codes J111, J118, J110, and J00. Using the intensity threshold methodology proposed by the US CDC in 2017, various thresholds were tested for alignment with the nineteen-week flu season as proposed by the South African NICD. This resulted in varying thresholds for each province. The respiratory disease season commences in May and ends in September. These findings were seen in hospitalization cases and medical insurance claim cases, particularly with influenza-positive cases in Baragwanath hospital for the year 2019. These statistically determined intensity thresholds and timing of the acute respiratory infectious disease season allow for improved surveillance and preparedness among the public and private healthcare.

Identifiants

pubmed: 36673827
pii: ijerph20021074
doi: 10.3390/ijerph20021074
pmc: PMC9858855
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet Glob Health. 2022 Jul;10(7):e961-e969
pubmed: 35597249
Am J Respir Crit Care Med. 2008 Sep 1;178(5):527-33
pubmed: 18556629
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
Vaccine. 2007 Jun 28;25(27):5086-96
pubmed: 17544181
J Allergy Clin Immunol. 2022 Nov 28;:
pubmed: 36494212
Curationis. 2019 May 29;42(1):e1-e9
pubmed: 31170800
Science. 2009 Jan 9;323(5911):240-4
pubmed: 19131626
Environ Health Perspect. 2010 May;118(5):620-6
pubmed: 20435552
Int J Environ Res Public Health. 2020 Aug 05;17(16):
pubmed: 32764257
Virus Res. 2004 Jul;103(1-2):31-3
pubmed: 15163485
Public Health Rep (1896). 1963 Jun;78(6):494-506
pubmed: 19316455
Ann Intern Med. 2001 Mar 20;134(6):509-17
pubmed: 11255530
Environ Res. 2021 May;196:110973
pubmed: 33684412
Influenza Other Respir Viruses. 2015 Sep;9(5):234-46
pubmed: 26031655
Euro Surveill. 2021 Jul;26(29):
pubmed: 34296675
Zh Mikrobiol Epidemiol Immunobiol. 1992;(11-12):37-40
pubmed: 1338742
Int J Epidemiol. 2006 Oct;35(5):1314-21
pubmed: 16926216
Open Forum Infect Dis. 2020 May 26;7(6):ofaa200
pubmed: 32617374
Am J Epidemiol. 2018 May 1;187(5):1040-1050
pubmed: 29053783
Arch Intern Med. 2003 Feb 24;163(4):487-94
pubmed: 12588210
Epidemiol Infect. 2006 Dec;134(6):1129-40
pubmed: 16959053

Auteurs

Ogone Motlogeloa (O)

School of Geography, Archaeology and Environmental Studies, University of the Witwatersrand, Johannesburg 2050, South Africa.

Jennifer M Fitchett (JM)

School of Geography, Archaeology and Environmental Studies, University of the Witwatersrand, Johannesburg 2050, South Africa.

Neville Sweijd (N)

Alliance for Collaboration on Climate and Earth Systems Science (ACCESS), Council for Scientific and Industrial Research (CSIR), Pretoria 0001, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH